PHARMACY

Par prepares for IPO

BY Ryan Chavis

CHESTNUT RIDGE, N.Y. — Par Pharmaceutical Holdings last week announced that it filed a statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock. The number of shares offered by the company and its shareholders, along with the price, haven’t been determined, according to a statement from Par. 
 
J.P. Morgan and Goldman, Sachs & Co. are working as joint managers as well as representatives of the underwriters for the proposed IPO. Additionally, Citigroup, Morgan Stanley, BofA Merrill Lynch, Deutsche Bank Securities and Evercore ISI are joint book-running managers for the offering, according to Par. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

NACDS’ point-of-care testing program to kick off with national tour

BY Antoinette Alexander

ARLINGTON, Va. — Illustrating its commitment to expanding access to patient services, the National Association of Chain Drug Stores has announced the expansion and acquisition of a certificate program designed to provide training for pharmacists to administer point-of-care testing and other health assessments in pharmacies.

The official kickoff of the Community Pharmacy-Based Point-of-Care Testing certificate program will begin in April with a multicity tour at colleges and universities of pharmacies nationwide. At each stop of the tour, participants will complete the certificate program on the first day and a “train-the-trainer” program on the second day so that they can learn how to teach the program to other pharmacists.
 
Designed for community pharmacy, academia and pharmacy association staff, the Community Pharmacy-Based Point-of-Care Testing certificate program will train participants to administer a variety of point-of-care tests, as well as health and physical assessments. Specifically, the accredited certificate program includes 20 hours of Continuing Pharmacy Education credit for those who successfully complete course requirements and assessments, including 12 hours of home study and eight hours of live training about disease states, physical assessments, point-of-care tests, collaborative practice models and business models.
 
The education and training of pharmacists qualifies them to provide a host of services, including point-of-care testing. Faculty at the University of Nebraska Medical Center and Ferris State University developed the NACDS point-of-care testing certificate program.
 
“While patients continue to look to their pharmacist as a steward of medication safety and effectiveness, more and more patients are looking to their pharmacists to provide innovative services that further help maintain their health and wellness, including point-of-care testing,” stated NACDS president and CEO Steve Anderson. “In light of the evolution of convenient and accessible healthcare care services, this NACDS certificate program demonstrates the education and training of pharmacists, and empowers greater access to services that can help improve patient health.”  
 
With support from Quidel, a manufacturer of diagnostic healthcare solutions, the registration fee for participants of the two-day training programs during the national tour will be waived.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Diplomat to raise $200 million in stock offering

BY Michael Johnsen

FLINT, Mich. — Diplomat Pharmacy announced Friday the filing of a registration statement with the Securities and Exchange Commission in connection with a proposed follow-on public offering of its common stock. Subject to market conditions, the offering could raise approximately $200 million. 
 
Diplomat expects to raise approximately $100 million of gross primary proceeds that will be used for working capital and other general corporate purposes, which may include debt repayment and/or future acquisitions. The selling shareholders and certain option holders, whose options will be repurchased by the company, will receive the remaining $100 million of gross proceeds expected to be raised in the offering. 
 
The company and selling shareholders intend to grant the underwriters a 30-day option to purchase additional shares of common stock.
 
Diplomat will not receive any proceeds from shares of common stock to be sold by the selling shareholders.
 
Credit Suisse Securities and Morgan Stanley are acting as lead book-running managers. Additional book-running managers are J.P. Morgan Securities and Wells Fargo Securities. William Blair & Company, Leerink Partners and Raymond James & Associates are acting as comanagers.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?